E-LIB Suche - Ergebnisse für: Manara, Paola

1

The Poly (ADP-ribose) polymerase inhibitor olaparib and pan..:

Han, Chanhee ; McNamara, Blair ; Bellone, Stefania...
Gynecologic Oncology. 170 (2023) - p. 172-178 , 2023

Link: https://doi.org/10.1016/..

2

Homologous recombination deficiency (HRD) signature-3 in ov..:

Tymon-Rosario, Joan ; Manara, Paola ; Manavella, Diego...
Gynecologic Oncology. 166 (2022) - p. S30 , 2022

Link: https://doi.org/10.1016/..

3

Homologous recombination deficiency (HRD) signature-3 in ov..:

Tymon-Rosario, Joan R. ; Manara, Paola ; Manavella, Diego D....
Gynecologic Oncology. 166 (2022) 1 - p. 117-125 , 2022

Link: https://doi.org/10.1016/..

4

DHES0815A, a novel antibody-drug conjugate targeting HER2/n..:

Tymon-Rosario, Joan ; Bonazzoli, Elena ; Bellone, Stefania...
Gynecologic Oncology. 163 (2021) 2 - p. 334-341 , 2021

Link: https://doi.org/10.1016/..

5

Proteomics reveal cap-dependent translation inhibitors remo..:

Ho, J.J. David ; Cunningham, Tyler A. ; Manara, Paola...
Cell Reports. 37 (2021) 2 - p. 109806 , 2021

Link: https://doi.org/10.1016/..

6

Cervical carcinomas that overexpress human trophoblast cell..:

Zeybek, Burak ; Manzano, Aranzazu ; Bianchi, Anna...
Scientific Reports. 10 (2020) 1 - p. , 2020

Link: https://doi.org/10.1038/..

7

Preclinical activity of sacituzumab govitecan (IMMU-132) in..:

Lopez, Salvatore ; Perrone, Emanuele ; Bellone, Stefania...
Oncotarget. 11 (2020) 5 - p. 560-570 , 2020

Link: https://doi.org/10.18632..

8

Sacituzumab govitecan, an antibody‐drug conjugate targeting..:

Perrone, Emanuele ; Manara, Paola ; Lopez, Salvatore...
Molecular Oncology. 14 (2020) 3 - p. 645-656 , 2020

Link: https://doi.org/10.1002/..

9

Preclinical Activity of Sacituzumab Govitecan, an Antibody-..:

Perrone, Emanuele ; Lopez, Salvatore ; Zeybek, Burak...
Frontiers in Oncology. 10 (2020) - p. , 2020

Link: https://doi.org/10.3389/..

10

Derangements in HUWE1/c-MYC pathway confer sensitivity to t..:

Bonazzoli, Elena ; Bellone, Stefania ; Zammataro, Luca...
Gynecologic Oncology. 158 (2020) 3 - p. 769-775 , 2020

Link: https://doi.org/10.1016/..

11

In vitro and in vivo activity of sacituzumab govitecan, an ..:

Han, Chanhee ; Perrone, Emanuele ; Zeybek, Burak...
Gynecologic Oncology. 156 (2020) 2 - p. 430-438 , 2020

Link: https://doi.org/10.1016/..

12

Whole-exome sequencing of cervical carcinomas identifies ac..:

Zammataro, Luca ; Lopez, Salvatore ; Bellone, Stefania...
Proceedings of the National Academy of Sciences. 116 (2019) 45 - p. 22730-22736 , 2019

Link: https://doi.org/10.1073/..

13

PI3K oncogenic mutations mediate resistance to afatinib in ..:

Bonazzoli, Elena ; Cocco, Emiliano ; Lopez, Salvatore...
Gynecologic Oncology. 153 (2019) 1 - p. 158-164 , 2019

Link: https://doi.org/10.1016/..

14

Mutational landscape of primary, metastatic, and recurrent ..:

Li, Charles ; Bonazzoli, Elena ; Bellone, Stefania...
Proceedings of the National Academy of Sciences of the United States of America. 116 (2019) 2 - p. 619-624 , 2019

Link: https://www.jstor.org/st..

15

PARP-1 activity (PAR) determines the sensitivity of cervica..:

Bianchi, Anna ; Lopez, Salvatore ; Altwerger, Gary...
Gynecologic Oncology. 155 (2019) 1 - p. 144-150 , 2019

Link: https://doi.org/10.1016/..